MEF2C Expression Is Regulated by the Post-transcriptional Activation of the METTL3-m6A-YTHDF1 Axis in Myoblast Differentiation

Xinran Yang, Yue Ning, Sayed Haidar Abbas Raza, Chugang Mei, Linsen ZanFrontiers in Veterinary Science 2022 · DOI

TL;DR

This study uncovers a novel regulatory pathway in skeletal muscle development, revealing that the METTL3-m6A-YTHDF1 axis post-transcriptionally activates MEF2C protein expression, crucial for myoblast differentiation. Furthermore, MEF2C reciprocally promotes METTL3 expression, establishing a positive feedback loop that enhances muscle growth and potentially offers new avenues for livestock breeding and muscle disease treatment.

What Problem Does This Paper Address?

Skeletal muscle growth and regeneration are complex processes vital for livestock production and meat quality. While epigenetic modifications like DNA and histone methylation are known players, the role of RNA modifications, specifically N<sup>6</sup>-methyladenosine (m<sup>6</sup>A), in skeletal myogenesis remains largely unexplored, particularly in cattle. Understanding these mechanisms is crucial for advancing molecular breeding strategies and addressing muscle-related disorders. This paper aims to elucidate the specific role and underlying molecular mechanisms of m<sup>6</sup>A modification in bovine skeletal myoblast differentiation.

Methods

The researchers employed a multi-pronged approach:

  • Cell Culture and Differentiation: Bovine skeletal myoblasts were cultured and induced to differentiate into myotubes.
  • Molecular Biology Techniques:
    • RT-qPCR: To quantify mRNA expression levels of key myogenic genes (MYOD1, MYOG, MYH3, MYMK) and m<sup>6</sup>A-related enzymes (METTL3, FTO, ALKBH5).
  • LC-MS/MS: To precisely measure the overall m<sup>6</sup>A levels in mRNA.
  • Dot Blotting: A qualitative method to assess m<sup>6</sup>A modification levels in RNA.
  • MeRIP-Seq (m<sup>6</sup>A RNA Immunoprecipitation Sequencing): To globally identify m<sup>6</sup>A-modified transcripts in myoblasts and myotubes.
  • RNA-Seq: To analyze global gene expression changes during differentiation.
  • Plasmid Construction and Transfection: To create wild-type and mutated MEF2C constructs, as well as vectors for knocking down or overexpressing METTL3, FTO, and YTHDF1.
  • siRNA Transfection: For gene knockdown experiments.
  • Western Blotting: To assess protein expression levels.
  • Immunofluorescence: To visualize protein localization and myotube formation.
  • Luciferase Reporter Assay: To investigate the regulatory role of METTL3 on MEF2C and MEF2C on METTL3 promoter activity.
  • Chromatin Immunoprecipitation (ChIP) Assay: To confirm MEF2C binding to the METTL3 promoter.
  • RNA Stability Assays: Using actinomycin D to assess mRNA half-life.

Datasets

Not explicitly detailed as separate datasets, but the study generated and analyzed:

  • MeRIP-Seq data: Identifying m<sup>6</sup>A peaks across the transcriptome of bovine myoblasts and myotubes.
  • RNA-Seq data: Profiling gene expression changes during myoblast differentiation.
  • Bioinformatic analysis: Integrated MeRIP-seq and RNA-seq data to identify differentially expressed genes and m<sup>6</sup>A-modified transcripts.

Key Insights and Ideas

  • Declining m<sup>6</sup>A during Differentiation: Surprisingly, overall m<sup>6</sup>A levels in mRNA decreased as bovine myoblasts differentiated, despite an increase in MEF2C mRNA and m<sup>6</sup>A levels. This suggests a complex, context-dependent role for m<sup>6</sup>A.
  • MEF2C as a Key Player: MEF2C, a known regulator of skeletal myogenesis, was found to be significantly upregulated during differentiation and its expression is directly influenced by m<sup>6</sup>A modification.
  • m<sup>6</sup>A-Dependent MEF2C Translation: The study demonstrates that METTL3, an m<sup>6</sup>A "writer," promotes MEF2C protein expression not by affecting mRNA stability, but through post-transcriptional regulation, specifically translation, mediated by the m<sup>6</sup>A "reader" YTHDF1.
  • Positive Feedback Loop: A crucial finding is the discovery of a positive feedback loop where MEF2C, a transcription factor, directly binds to the promoter of METTL3, thereby increasing METTL3 expression and, consequently, further enhancing MEF2C translation. This creates a self-reinforcing mechanism for myogenesis.
  • Conserved Regulatory Mechanism: The m<sup>6</sup>A modification site in MEF2C appears to be conserved across species, suggesting a potentially general regulatory mechanism for muscle development.

Key Results

  • MEF2C Knockdown Inhibits Differentiation: Silencing MEF2C significantly impaired myotube formation and fusion, and reduced the expression of key myogenic factors (MYOD1, MYOG, MYH3, MYMK).
  • MEF2C Overexpression Promotes Differentiation: Conversely, overexpressing MEF2C enhanced myotube formation and the expression of myogenic genes.
  • METTL3 Promotes MEF2C Protein: Knockdown of METTL3 reduced MEF2C protein levels, while its overexpression increased them.
  • YTHDF1 Mediates MEF2C Translation: YTHDF1 knockdown reduced MEF2C protein expression, and YTHDF1 was shown to directly bind to m<sup>6</sup>A-modified MEF2C mRNA.
  • MEF2C Binds METTL3 Promoter: ChIP assays confirmed that MEF2C directly binds to two specific sites in the METTL3 promoter, leading to increased METTL3 transcription.
  • Mutating m<sup>6</sup>A site in MEF2C Impairs Differentiation: A mutated MEF2C construct lacking the m<sup>6</sup>A modification site significantly inhibited myoblast differentiation compared to wild-type MEF2C.

Limitations and Future Work

  • Complexity of m<sup>6</sup>A Regulation: The study highlights that while overall m<sup>6</sup>A levels decrease during differentiation, specific transcripts like MEF2C show increased m<sup>6</sup>A modification. This suggests a complex regulatory network that warrants further investigation.
  • FTO's Role: While FTO (an m<sup>6</sup>A demethylase) was shown to affect MEF2C expression, its precise mechanism (e.g., affecting splicing or translation of different transcripts) requires further clarification.
  • Cell Culture vs. In Vivo: The study was conducted in vitro using cultured myoblasts. Future work could explore these mechanisms in vivo in animal models to confirm their physiological relevance.
  • Broader Applications: The authors suggest that these findings could inform molecular genetics and breeding in livestock, as well as therapeutic strategies for muscle-related diseases, indicating potential future research directions.

Summary updated

Abstract

<i>N</i> <sup>6</sup>-methyladenosine (m<sup>6</sup>A) plays an essential role in regulating gene expression. However, the effect of m<sup>6</sup>A on skeletal myoblast differentiation and the underlying mechanisms are still unclear. Here, we ascertained mRNA m<sup>6</sup>A methylation exhibited declined changes during bovine skeletal myoblast differentiation, and both <i>MEF2C</i> mRNA expression and m<sup>6</sup>A levels were significantly increased during myoblast differentiation. We found that <i>MEF2C</i> with mutated m<sup>6</sup>A sites significantly inhibited myoblast differentiation compared with wild-type <i>MEF2C</i>. METTL3 promoted MEF2C protein expression through posttranscriptional modification in an m<sup>6</sup>A-YTHDF1-dependent manner. Moreover, MEF2C promoted the expression of METTL3 by binding to its promoter. These results revealed that there is a positive feedback loop between these molecules in myoblast differentiation. Our study provided new insights into skeletal muscle differentiation and fusion, which may provide an RNA methylation-based approach for molecular genetics and breeding in livestock as well as for the treatment of muscle-related diseases.
BibTeX
@inproceedings{yang2022mef,
  author = {Xinran Yang and Yue Ning and Sayed Haidar Abbas Raza and Chugang Mei and Linsen Zan},
  title = {{MEF2C Expression Is Regulated by the Post-transcriptional Activation of the METTL3-m6A-YTHDF1 Axis in Myoblast Differentiation}},
  booktitle = {Frontiers in Veterinary Science},
  year = {2022},
  doi = {10.3389/fvets.2022.900924},
}
Figure